RSS

SNGX Soligenix Inc.

Mod: Add me as mod
Last Post: 04/21/26
Followers: 2
Posts Today: 0
Views Today: 2805

SNGX Stock Quote & Tools

$1.3900 ▲ +0.0200 (+1.46%) As of Apr 24, 4:00 PM EDT
Last1.3900
$ Chg0.0200
Open1.3700
High1.3900
Beta1.9376
Year High6.230
Market Cap14.33M
P/B Ratio2.67
EPS-2.14
Avg Vol (30d)325.5K
Volume64.2K
% Chg+1.46%
Prev Close1.3700
Low1.3400
VWAP1.36679
Year Low1.000
Total Shares10.31M
Shares Out10.31M
Float9.99M
ExchangeNCM
Healthcare Biotechnology & Life Sciences
Company Profile Buy Rating Time & Sales News Filings Financials

SNGX Stock Message Board Discussion

  1. NetworkNewsWire

    Soligenix Inc. (NASDAQ: SNGX) Reports Major Clinical Trial Milestones, Strategic Progress in

  2. NetworkNewsWire

    NetworkNewsBreaks Soligenix Inc. (NASDAQ: SNGX) Awarded FDA Orphan Drug Designation for

  3. NetworkNewsWire

    Study Finds That Low BSA Psoriasis Could Have a High Disease Burden For decades, the

  4. NetworkNewsWire

    Soligenix Inc. (NASDAQ: SNGX) Working to Advance Heat-Stable Ricin Vaccine with Promising

  5. NetworkNewsWire

    NetworkNewsBreaks Soligenix Inc. (NASDAQ: SNGX) Q2 2025 Results Highlight Progress in

  6. NetworkNewsWire

    NetworkNewsBreaks Alliance Global Partners Maintains Buy Rating, Increases Price Target as

  7. NetworkNewsWire

    NetworkNewsBreaks Soligenix Inc. (NASDAQ: SNGX) Featured in NNW Editorial on Rare Disease

  8. NetworkNewsWire

    Clinical Progress in Rare Disease Signals Long-Term Revenue Potential for Innovators

  9. NetworkNewsWire

    Study Finds That Inflammation Markers in Diabetics Influence Depression Treatment Outcomes

  10. NetworkNewsWire

    NetworkNewsBreaks Soligenix, Inc. (NASDAQ: SNGX) Spotlighted in Editorial on Rare Disease

  11. NetworkNewsWire

    Late-Stage Pipeline Wins Boost Investor Confidence in High-Growth Therapeutic Areas

  12. NetworkNewsWire

    NetworkNewsBreaks Soligenix Inc. (NASDAQ: SNGX) Achieves Biological Efficacy in Phase 2a

  13. NetworkNewsWire

    Global Vaccination Goals at Risk as 14 Million Kids Miss Crucial Shots Latest UN data

  14. NetworkNewsWire

    Soligenix Inc. (NASDAQ: SNGX) Pioneering Oral Mucositis Treatment with Novel Therapeutic,

  15. NetworkNewsWire

    Soligenix Inc. (NASDAQ: SNGX) Reports Strong Results in Real-World Trial - Recent data

  16. NetworkNewsWire

    NetworkNewsBreaks Zacks Research Releases Updated Report as Soligenix Inc. (NASDAQ: SNGX) Eyes

  17. NetworkNewsWire

    Dutch Startup Develops Highly Sensitive Field Test for Infectious Diseases Spotlight

  18. NetworkNewsWire

    NetworkNewsBreaks Soligenix Inc. (NASDAQ: SNGX) Targets Multiple 20252026 Catalysts Across

  19. NetworkNewsWire

    Soligenix Inc. (NASDAQ: SNGX) Highlights Encouraging Phase 3 Progress for HyBryte(TM) in

  20. NetworkNewsWire

    Research Finds That Pesticides Disrupt Inflammation-Linked Bacteria Existing scientific

  21. NetworkNewsWire

    NetworkNewsBreaks Soligenix Inc. (NASDAQ: SNGX) Advancing Novel Immunotherapy to Combat

  22. NetworkNewsWire

    Soligenix Inc. (NASDAQ: SNGX) Proprietary Therapy Shows Promise in Treatment of Psoriasis

  23. NetworkNewsWire

    Study Finds the Overall Prevalence of Psoriasis in the US Unchanged A recently published

  24. NetworkNewsWire

    Soligenix Inc. (NASDAQ: SNGX) Makes Advancement in Proprietary Treatment for Behets

  25. NetworkNewsWire

    NetworkNewsBreaks Soligenix Inc. (NASDAQ: SNGX) Advances Clinical Programs, Eyes Critical

  26. NetworkNewsWire

    Soligenix Inc. (NASDAQ: SNGX) Offers Hope on the Horizon with HyBryte(TM) Treatment Targeting

  27. NetworkNewsWire

    Therapeutic Target Shows Promise in Preventing Cancer Resulting from Chronic Gut

  28. NetworkNewsWire

    NetworkNewsBreaks Soligenix Inc. (SNGX) Highlights HyBryte Progress in CTCL via New Podcast

  29. NetworkNewsWire

    New Swallowable Pill Provides Real-Time Gut Inflammation Tracking The GI tract and its

  30. NetworkNewsWire

    Soligenix Inc. (NASDAQ: SNGX) Innovative Treatment to Combat Bacterial Infection Fills Urgent

  31. NetworkNewsWire

    NetworkNewsBreaks Soligenix Inc.s (NASDAQ: SNGX) HyBryte(TM) Delivers Strong Results in Rare

  32. chris121

    If you're using QuickBooks Premier to manage your accounting, inventory, or payroll, issues can pop

  33. NetworkNewsWire

    Soligenix Inc. (NASDAQ: SNGX) Reports Q1 Milestones, Financial Results - Q1 milestones

  34. NetworkNewsWire

    NetworkNewsBreaks Zacks Research Issues Business Update as Soligenix Inc. (NASDAQ: SNGX)

  35. NetworkNewsWire

    Study Links Higher Consumption of Ultra-Processed Foods to Heightened Psoriasis Risk A

  36. NetworkNewsWire

    NetworkNewsBreaks Soligenix Inc (SNGX) CEO Highlights Pipeline and Strategy in Latest

  37. NetworkNewsWire

    Bacterial Meningitis Can Now Be Rapidly Diagnosed with New Test A team of researchers

  38. NetworkNewsWire

    Soligenix Inc. (NASDAQ: SNGX) HyBryte(TM) Paves Way for Breakthrough Treatment for Rare Skin

  39. NetworkNewsWire

    NetworkNewsBreaks Soligenix Inc. (NASDAQ: SNGX) Moves Forward to Strengthen the Case for

  40. NetworkNewsWire

    NetworkNewsBreaks Soligenix Inc. (NASDAQ: SNGX) Featured in Benzinga Video Highlighting 75%

  41. NetworkNewsWire

    Study Finds Link Between Childhood Maltreatment and Elevated Risk of Psoriasis, Rheumatoid

  42. NetworkNewsWire

    Soligenix Inc. (NASDAQ: SNGX) Advances CiVax Amid Ongoing COVID-19 Threat - An increase

  43. NetworkNewsWire

    NetworkNewsBreaks Soligenix Inc. (NASDAQ: SNGX) Announces Positive Data, Continued Advancement

  44. NetworkNewsWire

    Study Shows the Gut is Key in Protecting the Brain After Stroke Many patients who have

  45. NetworkNewsWire

    Soligenix Inc. (NASDAQ: SNGX) Spotlighted in Recent Zacks Small-Cap Research Report, Earns a $35

  46. NetworkNewsWire

    Soligenix Inc. (NASDAQ: SNGX) Advances Phase 3 Replication Study for Early-Stage Cutaneous

  47. NetworkNewsWire

    NetworkNewsBreaks Zacks Maintains $35.00 Price Per Share Valuation for Soligenix Inc. (NASDAQ:

  48. NetworkNewsWire

    NetworkNewsBreaks Soligenix Inc. (NASDAQ: SNGX) Taps IBN to Lead Corporate Communications

  49. NetworkNewsWire

    NetworkNewsBreaks Soligenix Inc. (NASDAQ: SNGX) Announces Key Milestones and 2024 Financial

  50. NetworkNewsWire

    Study Shows Bioengineered Materials Can Treat Oral Mucositis New research that appeared